prednimustine has been researched along with Vomiting in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boesen, E; Mouridsen, HT | 1 |
Dombernowsky, P; Kristensen, D; Mouridsen, HT; Nielsen, JH | 1 |
Murphy, GP; Slack, NH | 1 |
Dusleag, J; Kasparek, AK; Lechner, P; Pfeiffer, K; Samonigg, H; Schmid, M; Smola, M; Steindorfer, P; Stöger, H | 1 |
4 other study(ies) available for prednimustine and Vomiting
Article | Year |
---|---|
Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.
Topics: Aged; Alopecia; Breast Neoplasms; Chlorambucil; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Nausea; Pilot Projects; Prednimustine; Tamoxifen; Vomiting | 1982 |
Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Chlorambucil; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nausea; Prednimustine; Psychoses, Substance-Induced; Thrombocytopenia; Time Factors; Vomiting | 1980 |
Prednimustine for prostate cancer therapy.
Topics: Chlorambucil; Estramustine; Hematopoiesis; Humans; Male; Nausea; Prednimustine; Prostatic Neoplasms; Vomiting | 1979 |
Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chi-Square Distribution; Drug Evaluation; Female; Fluorouracil; Humans; Leukopenia; Middle Aged; Mitoxantrone; Nausea; Prednimustine; Remission Induction; Survival Rate; Thrombocytopenia; Vomiting | 1991 |